RxDoctor Payments Data

Antoine Salloum, MD

Dermatology · Middletown, RINPI 1134790157

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations.

$3,591in general payments, 2019–2025

Across 105 payments — averaging $34.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$595
  • Pfizer$387
  • E.r. Squibb & Sons, L.L.C.$372
  • Sanofi$306
  • LEO Pharma Inc.$282
  • Gilead$220
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,49697%
  • Education$953%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,591 in reported general payments places this provider in the 70th percentile of 61 dermatology providers in Rhode Island.

See all dermatology providers in Rhode Island

Medicare billing

Part B allowed, 2024
$229,726
Medicare patients
493
Services billed
3,809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Dipropionate154$5,903
Tacrolimus41$5,450
Ketoconazole327$5,123
Triamcinolone Acetonide281$4,259
Clobetasol Propionate57$3,625
Azelaic Acid35$3,063
Metronidazole33$2,406
Fluocinonide72$2,353
Clindamycin Phosphate33$1,984
Doxycycline Hyclate164$1,558
Econazole Nitrate26$951
Mupirocin97$733
Hydrocortisone45$408
Ammonium Lactate11$286
Ciclopirox12$278

Paid to pharmacies, not to this prescriber.

Other dermatology in Middletown

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →